|
EBX-102 Clinical Trials
1 actively recruiting trial
Also known as: IMT capsules
Pipeline
Phase 2: 1
Top Sponsors
- Imperial College London1
Indications
- Chronic Myeloid Leukemia1
- Acute Lymphoblastic Leukaemia1
- Chronic Myelomonocytic Leukemia1
- Acute Leukemia of Ambiguous Lineage1
- Myelodysplastic Syndrome1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.